Report #2856221

Received Sep 1, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: NE
Recovered: Unknown
Vaccinated: Aug 12, 2025
Onset: Aug 12, 2025
Days to onset: 0
Hospital days: —

Vaccines (2)

Type	Name	Manufacturer	Dose	Lot	Route / Site
MMRV	MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)	MERCK & CO. INC.	UNK	Y019176	OT
MMRV	MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)	MERCK & CO. INC.	UNK	—	OT

Symptoms (2)

No adverse eventProduct storage error

Symptom narrative

No additional AE; TE. PROQUAD was administered to one patient; This spontaneous report was received from a Nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 12-Aug-2025, the patient was vaccinated with a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), Injection (lot #Y019176, expiration date: 18-May-2026) 0.5 mL administered by Unknown route. The vaccine was reconstituted with sterile diluent (Hollister-Stier STERILE DILUENT), administered by Unknown route (lot # and expiration date were not reported). as Prophylaxis. Previously to the administration, the vaccine had a temperature excursion of 2.2C for 2 hours 48 minutes 0 seconds. The vaccine also had a previous temperature excursion. No additional adverse event (AE).